Hims & Hers Health HIMS
$14.60 −$1.42 (-8.86%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $15.13 +3.63%
Open$15.51
Prev close$16.02
Day range$14.51 – $15.96
Volume16.13M
Market cap$3.42B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$890.37M+48.6% YoY
Operating profit-$66.15M-660.2% YoY
Net profit-$33.04M-309.5% YoY
Diluted EPS-$0.14-333.3% YoY
Free cash flow$25.97M-67.3% YoY
Operating cash flow$65.39M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin63.8%
Operating margin-8.1%
Net margin-6.7%
Return on equity-40.8%
Return on assets-6.6%
Return on invested capital-10.6%
Current ratio0.92
Liabilities / assets90.0%
Cash & investments$712.22M
Total debt$1.55B
Net cash (debt)-$837.69M
Free cash flow / sales0.3%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $890.37M | $753.21M | $608.10M | $2.35B | $617.82M |
| Total Operating Revenue | $890.37M | $753.21M | $608.10M | $2.35B | $617.82M |
| Cost of Revenue | $381.17M | $272.41M | $211.32M | $614.26M | $173.38M |
| Gross Profit | $509.20M | $480.80M | $396.79M | $1.73B | $444.44M |
| Operating Expense | $575.35M | $578.00M | $475.11M | $1.63B | $435.25M |
| Selling and Admin Expenses | $398.76M | $427.61M | $331.67M | $1.19B | $314.21M |
| -Selling & Marketing Expense | $247.28M | $262.24M | $222.00M | $919.30M | $238.05M |
| -General & Admin Expense | $151.48M | $165.38M | $109.67M | $272.72M | $76.17M |
| Research & Development | $69.39M | $54.90M | $46.94M | $149.30M | $40.96M |
| Other Operating Expenses | $107.20M | $95.48M | $96.50M | $286.44M | $80.07M |
| Operating Profit | -$66.15M | -$97.19M | -$78.32M | $105.61M | $9.19M |
| Other Income (Expense) | $19.90M | $4.56M | -$23.23M | $18.31M | $9.17M |
| Gain on Sale of Security | $21.11M | $4.74M | -$9.68M | $4.44M | – |
| Other Non-Operating Income (Expenses) | -$1.22M | -$178,000.00 | -$13.55M | $13.87M | $4.73M |
| Pretax Profit | -$46.25M | -$92.63M | -$101.55M | $123.92M | $18.35M |
| Tax | -$13.21M | -$6.34M | -$9.44M | -$4.44M | -$2.25M |
| Net Profit | -$33.04M | -$86.29M | -$92.12M | $128.37M | $20.60M |
| Profit from Continuing Operations | -$33.04M | -$86.29M | -$92.12M | $128.37M | $20.60M |
| Net Income to Parent Company | -$33.04M | -$86.29M | -$92.12M | $128.37M | $20.60M |
| Net Income to Common Stockholders | -$33.04M | -$86.29M | -$92.12M | $128.37M | $20.60M |
| Basic EPS | -$0.14 | -$0.37 | -$0.40 | $0.57 | $0.09 |
| Diluted EPS | -$0.14 | -$0.37 | -$0.40 | $0.51 | $0.08 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $3.55B | $3.63B | $2.27B | $2.15B | $2.15B |
| Total Current Assets | $1.32B | $1.38B | $1.05B | $767.64M | $767.64M |
| Cash and Cash Equivalents & Short-Term Investments | $712.22M | $841.05M | $750.88M | $577.49M | $577.49M |
| -Cash and Cash Equivalents | $605.60M | $609.81M | $222.27M | $228.62M | $228.62M |
| -Short Term Investments | $106.62M | $231.24M | $528.61M | $348.88M | $348.88M |
| Receivables | $427.85M | $375.29M | $149.62M | $32.15M | $32.15M |
| -Accounts Receivable | $427.85M | $375.29M | $149.62M | $32.15M | $32.15M |
| Prepaid Assets | $50.62M | $68.81M | $55.19M | $73.50M | $73.50M |
| Inventory | $107.85M | $87.78M | $79.07M | $80.13M | $80.13M |
| Other Current Assets | $22.57M | $11.69M | $10.61M | $4.37M | $4.37M |
| Total Non-Current Assets | $2.23B | $2.24B | $1.22B | $1.39B | $1.39B |
| Net PPE | $567.94M | $529.78M | $478.09M | $448.98M | $448.98M |
| -Gross PPE | $649.34M | $600.96M | $539.92M | $501.57M | $501.57M |
| -Accumulated Depreciation | -$81.40M | -$71.18M | -$61.83M | -$52.59M | -$52.59M |
| Investments and Advances | $0.00 | $0.00 | $0.00 | $351.26M | $351.26M |
| Goodwill and Other Intangible Assets | $1.51B | $1.52B | $603.87M | $474.44M | $474.44M |
| -Goodwill | $1.11B | $1.10B | $342.84M | $278.33M | $278.33M |
| -Other Intangible Assets | $397.26M | $422.81M | $261.03M | $196.12M | $196.12M |
| Non-Current Deferred Assets | $121.12M | $111.58M | $92.09M | $82.71M | $82.71M |
| Other Non-Current Assets | $28.76M | $78.31M | $47.63M | $29.68M | $29.68M |
| Total Liabilities | $3.19B | $3.30B | $1.82B | $1.61B | $1.61B |
| Total Current Liabilities | $1.44B | $1.48B | $618.78M | $404.43M | $404.43M |
| Payables | $1.02B | $1.07B | $361.04M | $199.90M | $199.90M |
| -Accounts Payable | $515.69M | $501.30M | $306.87M | $143.28M | $143.28M |
| -Total Tax Payable | $24.91M | $28.31M | $14.08M | $9.64M | $9.64M |
| -Other Payable | $478.60M | $537.38M | $40.10M | $46.99M | $46.99M |
| Current Accrued Expenses | $175.19M | $181.95M | $76.67M | $68.88M | $68.88M |
| Short-Term Debt and Capital Lease Obligation | $10.85M | $11.55M | $5.58M | $4.84M | $4.84M |
| -Current Capital Lease Obligation | $10.85M | $11.55M | $5.58M | $4.84M | $4.84M |
| Current Deferred Liabilities | $144.07M | $141.38M | $165.13M | $127.16M | $127.16M |
| Other Current Liabilities | $86.64M | $81.36M | $10.36M | $3.65M | $3.65M |
| Total Non-Current Liabilities | $1.76B | $1.82B | $1.20B | $1.21B | $1.21B |
| Long Term Accounts Payable and Other Payables | $84.50M | $165.62M | $26.94M | – | – |
| Long Term Debt and Capital Lease Obligation | $1.55B | $1.53B | $1.13B | $1.12B | $1.12B |
| -Long Term Debt | $1.37B | $1.37B | $974.11M | $972.58M | $972.58M |
| -Long Term Capital Lease Obligation | $182.51M | $169.39M | $152.35M | $143.17M | $143.17M |
| Non-Current Deferred Liabilities | $27.96M | $30.93M | $23.51M | $28.86M | $28.86M |
| Other Non-Current Liabilities | $93.25M | $90.26M | $25.19M | $64.74M | $64.74M |
| Total Equity | $355.30M | $324.07M | $446.17M | $540.93M | $540.93M |
| Stockholders' Equity | $355.30M | $324.07M | $446.17M | $540.93M | $540.93M |
| Capital Stock | $23,000.00 | $23,000.00 | $23,000.00 | $23,000.00 | $23,000.00 |
| -Common Stock | $23,000.00 | $23,000.00 | $23,000.00 | $23,000.00 | $23,000.00 |
| Additional Paid-In Capital | $711.25M | $662.26M | $656.44M | $652.38M | $652.38M |
| Retained Earnings | -$325.22M | -$292.18M | -$205.89M | -$113.77M | -$113.77M |
| Gains/Losses Not Affecting Retained Earnings | -$30.76M | -$46.04M | -$4.41M | $2.29M | $2.29M |
| -Available for Sale Securities | – | – | – | $351.26M | $351.26M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $65.39M | -$35.94M | $89.36M | $300.01M | $61.31M |
| Net cash flow from continuing operations | $65.39M | -$35.94M | $89.36M | $300.01M | $61.31M |
| Net Income from Continuing Operations | -$33.04M | -$86.29M | -$92.12M | $128.37M | $20.60M |
| Depreciation & Depletion & Amortization | $38.21M | $29.48M | $21.95M | $54.50M | $18.09M |
| Deferred Tax | -$12.79M | -$9.36M | -$13.98M | -$12.96M | -$3.48M |
| Other Non-Cash Items | $29.52M | $27.55M | $59.74M | $29.96M | $8.80M |
| Change in Working Capital | -$20,000.00 | -$35.75M | $67.45M | -$29.16M | -$12.04M |
| -Change in Receivables | $68,000.00 | -$219.80M | -$116.25M | – | – |
| -Change in Inventory | -$20.96M | $6.05M | -$20.30M | -$13.72M | $26.38M |
| -Change in Prepaid Assets | $11.96M | -$565,000.00 | $645,000.00 | -$51.86M | -$13.59M |
| -Change in Payables and Accrued Expense | $5.04M | $238.19M | $175.60M | -$12.76M | -$47.71M |
| -Change in Other Current Assets | $5.25M | -$22.19M | -$8.36M | -$518,000.00 | -$513,000.00 |
| -Change in Other Current Liabilities | -$3.61M | -$2.41M | -$1.86M | -$1.91M | -$1.25M |
| -Change In Other Working Capital | $2.24M | -$35.02M | $37.98M | $51.60M | $8.53M |
| Net cash flow from investing | -$55.42M | $84.54M | -$15.45M | -$1.02B | -$83.68M |
| Net Cash Flow from Continuing Investing Activities | -$55.42M | $84.54M | -$15.45M | -$1.02B | -$83.68M |
| Net PPE Purchase and Sale | -$33.28M | -$25.93M | -$29.84M | -$226.05M | -$59.39M |
| Net Intangibles Purchase and Sale | -$6.14M | -$6.33M | -$6.48M | -$16.55M | -$4.49M |
| Net Business Purchase and Sale | -$130.35M | -$180.24M | -$137.87M | -$145.23M | -$23.45M |
| Net Investment Purchase and Sale | $114.34M | $297.03M | $158.74M | -$637.14M | $3.66M |
| Financing Cash Flow | -$18.92M | $341.76M | -$77.88M | $729.62M | -$97.52M |
| Net Cash Flow from Continuing Financing Activities | -$18.92M | $341.76M | -$77.88M | $729.62M | -$97.52M |
| Net Issuance Payments Of Debt | $0.00 | – | – | $970.00M | $0.00 |
| Proceeds from Stock Option Exercised | $252,000.00 | $11.87M | $5.01M | $17.47M | $4.71M |
| Net Other Financing Charges | -$19.18M | -$60.54M | -$82.89M | -$167.89M | -$21.75M |
| Ending Cash Balance | $605.60M | $609.81M | $222.27M | $228.62M | $228.62M |
| Net Change in Cash | -$8.95M | $390.35M | -$3.97M | $4.67M | -$119.89M |
| Beginning Cash Balance | $609.81M | $222.27M | $228.62M | $221.44M | $345.78M |
| Effect of Exchange Rate Changes | $4.75M | -$2.81M | -$2.38M | $2.51M | $2.72M |
| Free Cash Flow | $25.97M | -$68.19M | $53.03M | $57.42M | -$2.57M |
| Net Common Stock Issuance | – | – | – | -$89.96M | -$80.48M |
No comments yet — be the first to weigh in on HIMS.
Sign in to join the discussion.